March 31 (Reuters) - CRISPR Therapeutics AG:
* CRISPR THERAPEUTICS AG - SUPPLEMENTING RISK FACTORS ON FORM 10-K WITH POTENTIAL IMPACTS FROM CORONAVIRUS PANDEMIC - SEC FILING Source text: bit.ly/3bHHC8s Further company coverage:
Our Standards:The Thomson Reuters Trust Principles.
